ALDURAZYME 2.9 mg/5mL
laronidase · INJECTION, SOLUTION, CONCENTRATE · Genzyme Corporation
ALDURAZYME is a injection, solution, concentrate containing laronidase at 2.9 mg/5mL, taken intravenous. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- ALDURAZYME
- Generic Name
- laronidase
- NDC Code (Product)
58468-0070- Manufacturer
- Genzyme Corporation
- Strength
- 2.9 mg/5mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125058
- Drug Class
- Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
- Marketing Start
- 04/30/2003
Recall History
No Recall HistoryFrequently Asked Questions
What is ALDURAZYME used for?
ALDURAZYME contains laronidase. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is ALDURAZYME a controlled substance?
ALDURAZYME is not classified as a controlled substance by the DEA.
What is the generic name for ALDURAZYME?
The generic name for ALDURAZYME is laronidase. There are no other listed brand versions of laronidase.
What is the NDC code for ALDURAZYME 2.9 mg/5mL?
The NDC (National Drug Code) for ALDURAZYME 2.9 mg/5mL is 58468-0070, listed by Genzyme Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)